Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

131.59
Delayed Data
As of Jun 23
 -0.11 / -0.08%
Today’s Change
97.52
Today|||52-Week Range
169.89
-8.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues412.6M408.2M409.0M370.5M
 
 
 
 
 
Cost of Goods Sold12.1M15.4M20.6M6.4M
 
 
 
 
 
Depreciation And Amortization7.9M8.2M7.8M7.9M
 
 
 
 
 
 
Operating ExpensesGross Income392.6M384.6M380.6M356.2M
 
 
 
 
 
General Expenses107.4M146.0M206.4M92.6M
 
 
 
 
 
Research And Development35.2M45.9M66.9M36.2M
 
 
 
 
 
Total Operating Expenses127.4M169.6M234.8M106.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income285.2M238.6M174.2M263.6M
 
 
 
 
 
Interest Expense On Debt600.0K500.0K2.2M800.0K
 
 
 
 
 
Other Expenses1.1M1.0M-500.0K800.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income285.7M239.1M171.5M263.6M
 
 
 
 
 
Income Taxes-79.6M-77.3M-61.2M-85.0M
 
 
 
 
 
Net Income206.1M161.8M110.3M178.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.3M43.2M42.2M44.5M
 
 
 
 
 
Shares To Calculate EPS Diluted46.9M46.2M45.4M45.9M
 
 
 
 
 
 
Earnings Per ShareEPS$4.39$3.50$2.43$3.89
 
 
 
 
 
EPS Diluted$4.39$3.50$2.43$3.89